BNH Investment logo

BNH Investment

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

BNH Investment is an investment company for bio and healthcare sectors.

Investor Profile

BNH Investment has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in South Korea.
  • Strong thematic focus on Software, Analytics, Artificial Intelligence (AI).

Stage Focus

  • Series B (100%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Software
  • Analytics
  • Artificial Intelligence (Ai)
  • Health Care
  • Information Technology
  • Health Diagnostics
  • Oncology
  • Software Engineering
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BNH Investment frequently co-invest with?

HB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
DS Investment & Securities
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
Ulmus Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Devsisters Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Shinyoung Securities
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
BSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BonAngels Venture Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
HRZ
North America, California, United States, Menlo Park
Co-Investments: 1
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by BNH Investment?

ENCell

Seoul, Seoul-t'ukpyolsi, South Korea

ENCell is a biotech company that develops and manufactures biopharmaceuticals.

BiotechnologyManufacturingPharmaceutical
Post Ipo DebtDec 4, 2025
Amount Raised: $15,270,982
Portrai

Seoul, Seoul-t'ukpyolsi, South Korea

Portrai is a biotechnology research company utilizing AI in spatial transcriptomics to improve biopsy quality.

Biotechnology
Series BDec 2, 2025
Amount Raised: $9,879,870
MediMabBio

Seongnam, Kyonggi-do, South Korea

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

BiotechnologyHealth CarePharmaceutical
Series BOct 24, 2025
Amount Raised: $17,790,379
Oncosoft

Seoul, Seoul-t'ukpyolsi, South Korea

Oncosoft develops anti-cancer treatment software to detect cancer.

Health DiagnosticsOncologySoftwareSoftware Engineering
Series BSep 23, 2024
Amount Raised: $8,245,012
AITRICS

Seocho, Seoul-t'ukpyolsi, South Korea

AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence.

AnalyticsArtificial Intelligence (AI)Health CareInformation TechnologySoftware
Series BMar 21, 2024
Amount Raised: $20,299,925

Find More Investors Like BNH Investment

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides